IMMU Quote, Trading Chart, Immunomedics Inc.
home / stock / immu / immu quote
$87.86 Last:
0.05% Change Percent:
$87.85 Open:
$87.86 Previous Close:
$87.93 High:
$87.59 Low:
15,282,019 Volume:
10/22/2020 04:56:50 pm Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
IMMU Last Five Trading Days
| Stock Date | Open Price | Close Price | High | Low | Volume |
|---|---|---|---|---|---|
| 2020-10-22 | 87.85 | 87.86 | 87.93 | 87.59 | 15,282,019 |
| 2020-10-21 | 87.75 | 87.82 | 87.82 | 87.72 | 5,345,257 |
| 2020-10-20 | 87.68 | 87.72 | 87.725 | 87.65 | 2,934,955 |
| 2020-10-19 | 87.62 | 87.61 | 87.6804 | 87.59 | 4,236,326 |
| 2020-10-16 | 87.55 | 87.56 | 87.64 | 87.47 | 4,393,342 |
| 2020-10-15 | 87.45 | 87.49 | 87.55 | 87.4 | 4,909,114 |
| 2020-10-14 | 87.57 | 87.43 | 87.58 | 87.43 | 11,987,998 |
| 2020-10-13 | 86.23 | 86.53 | 86.65 | 86.23 | 3,133,922 |
| 2020-10-12 | 86.2 | 86.1 | 86.49 | 85.96 | 3,675,979 |
| 2020-10-09 | 85.74 | 86 | 86.05 | 85.67 | 3,290,446 |
| 2020-10-08 | 85.45 | 85.73 | 85.75 | 85.41 | 2,033,946 |
| 2020-10-07 | 85.72 | 85.36 | 85.79 | 85.36 | 2,972,515 |
| 2020-10-06 | 85.6 | 85.61 | 85.85 | 85.5 | 2,791,782 |
| 2020-10-05 | 85.16 | 85.87 | 85.87 | 85.03 | 3,681,008 |
| 2020-10-02 | 84.95 | 85.08 | 85.3 | 84.9 | 3,404,219 |
| 2020-10-01 | 85.05 | 84.92 | 85.35 | 84.9 | 3,334,547 |
| 2020-09-30 | 85.21 | 85.03 | 85.33 | 84.84 | 5,646,516 |
| 2020-09-29 | 85.4 | 85.25 | 85.48 | 85.16 | 3,418,747 |
| 2020-09-25 | 85.25 | 85.36 | 85.4 | 85.1 | 3,742,182 |
| 2020-09-24 | 85.58 | 85.3 | 85.58 | 85.03 | 5,278,115 |
News, Short Squeeze, Breakout and More Instantly...
-
Gilead Sciences (NASDAQ: GILD) can be both a hero and a goat, depending on your perspective as an investor. The stock price rose from $17 in July 2010 to $118 in July 2015, as the company introduced revolutionary HIV drugs and helped bring a cure for hepatitis C to market. Since the...
-
With huge investments being made in biotech thanks to the pandemic, there has been a renewed focus on biotech stocks. Here are three worth considering: Amgen (AMGN), Immunomedics (IMMU), Seattle Genetics (SGEN), and Genmab (GMAB). The biotechnology industry has rightfully received a huge ...
-
MORRIS PLAINS, N.J., Oct. 12, 2020 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (NASDAQ: IMMU) (“Immunomedics” or the “Company”), a leading biopharmaceutical company in the area of antibody-drug conjugates, today announced that the Office of Orphan Products...